4D Molecular Therapeutics, Inc.
FDMT
$14.34
-$0.29-1.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.23% | 21.61% | -5.23% | -39.22% | -45.89% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 69.07% | 30.04% | 4.22% | -17.50% | -5.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 26.27% | 21.89% | -5.01% | -38.84% | -45.12% |
|
|
|||||
| Total Current Assets | 26.27% | 21.89% | -5.01% | -38.84% | -45.12% |
| Net Property, Plant & Equipment | -22.14% | -20.89% | -18.71% | -15.78% | 26.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.79% | 39.97% | 115.63% | 227.51% | 304.74% |
| Total Assets | 4.01% | -0.55% | 1.13% | -29.81% | -23.62% |
|
|
|||||
| Total Accounts Payable | 43.93% | 253.94% | 154.42% | 134.71% | 153.57% |
| Total Accrued Expenses | 32.52% | 41.12% | 42.42% | 12.95% | 50.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -6.07% | -3.40% | -0.80% | 11.86% | 79.01% |
| Total Finance Division Other Current Liabilities | 307.69% | -58.43% | 40.08% | 928.57% | -- |
| Total Other Current Liabilities | 307.69% | -58.43% | 40.08% | 928.57% | -- |
| Total Current Liabilities | 37.48% | 61.36% | 50.90% | 25.94% | 78.72% |
|
|
|||||
| Total Current Liabilities | 37.48% | 61.36% | 50.90% | 25.94% | 78.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.86% | -17.19% | -16.60% | -16.08% | 65.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 381.79% | 180.39% | -25.24% | -29.27% | -62.70% |
| Total Liabilities | 61.06% | 32.74% | 22.64% | 7.67% | 65.99% |
|
|
|||||
| Common Stock & APIC | 15.17% | 13.12% | 12.39% | 2.38% | 2.62% |
| Retained Earnings | -26.39% | -25.78% | -24.32% | -39.73% | -40.64% |
| Treasury Stock & Other | -232.34% | -154.22% | 217.47% | -37.81% | 215.02% |
| Total Common Equity | -3.14% | -3.81% | -0.97% | -33.27% | -28.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.14% | -3.81% | -0.97% | -33.27% | -28.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.14% | -3.81% | -0.97% | -33.27% | -28.46% |
|
|
|||||